| 000 | 01044 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515031556.0 | ||
| 264 | 0 | _c20060824 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0735-7907 | ||
| 024 | 7 |
_a10.1080/07357900600705516 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchlesselman, James J | |
| 245 | 0 | 0 |
_aPhase II clinical trials in oncology: strengths and limitations of two-stage designs. _h[electronic resource] |
| 260 |
_bCancer investigation _c |
||
| 300 |
_a404-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedical Oncology _xstandards |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSample Size |
| 700 | 1 | _aReis, Isildinha M | |
| 773 | 0 |
_tCancer investigation _gvol. 24 _gno. 4 _gp. 404-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/07357900600705516 _zAvailable from publisher's website |
| 999 |
_c16372478 _d16372478 |
||